Entera Bio Ltd. (ENTX) Q1 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Entera Bio Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:02.711 Greetings and welcome to Interrobio's 00:00:02.711 -- 00:00:07.774 first quarter 22 update conference call. At this time, all participants are 00:00:07.774 -- 00:00:12.397 in a listen-only mode. The question and answer session will follow the formal presentation. 00:00:12.397 -- 00:00:17.381 If anyone should require operator assistance during the conference, please press star 00:00:17.381 -- 00:00:22.584 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:22.584 -- 00:00:26.047 I would now like to turn the call over to Rich Cockrell of Investor Relations. 00:00:26.047 -- 00:00:27.668 Thank you. You may begin. 00:00:27.668 -- 00:00:33.175 Good morning and welcome to the call. Joining me today are Spiros Dramas, our Chief Executive 00:00:33.175 -- 00:00:38.357 Officer, and Miranda Teledano, Chief Business Officer, Chief Financial 00:00:38.357 -- 00:00:40.838 Officer, and Head of Strategy. 00:00:40.838 -- 00:00:45.720 A press release announcing Interis financial and operating results for the first quarter 00:00:45.720 -- 00:00:47.880 ended March 00:00:47.880 -- 00:00:49.341 31st, 2022, 00:00:49.341 -- 00:00:53.151 was issued on May 12th, 2022. 00:00:53.222 -- 00:00:57.424 For those of you who have not received it, it is available on the company's website in 00:00:57.424 -- 00:01:01.836 the investor section. at www.interrobio.com. 00:01:03.678 -- 00:01:07.700 Before we begin our prepared remarks, I would like to remind you that various statements 00:01:07.700 -- 00:01:14.104 the company makes during this call about future results in operations and financial positions 00:01:14.104 -- 00:01:19.526 are or interpretations of data from completed and ongoing trials, 00:01:19.526 -- 00:01:24.629 business str...